Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouse

Trehalose, a non-reducing disaccharide, induces autophagy. Trehalose mitigates insulin resistance and adipocyte hypertrophy in obese mice; however, its effect on the development of nonalcoholic steatohepatitis (NASH) associated with type 2 diabetes remains unknown. In this study, we investigated the...

Full description

Bibliographic Details
Main Authors: Kazutoshi Murotomi, Shigeyuki Arai, Aki Suyama, Akira Harashima, Yoshihiro Nakajima
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464619301379
_version_ 1818667274667556864
author Kazutoshi Murotomi
Shigeyuki Arai
Aki Suyama
Akira Harashima
Yoshihiro Nakajima
author_facet Kazutoshi Murotomi
Shigeyuki Arai
Aki Suyama
Akira Harashima
Yoshihiro Nakajima
author_sort Kazutoshi Murotomi
collection DOAJ
description Trehalose, a non-reducing disaccharide, induces autophagy. Trehalose mitigates insulin resistance and adipocyte hypertrophy in obese mice; however, its effect on the development of nonalcoholic steatohepatitis (NASH) associated with type 2 diabetes remains unknown. In this study, we investigated the effect of trehalose on the development of NASH in the Tsumura Suzuki Obese Diabetes (TSOD) mouse, a metabolic syndrome model characterized by obesity, type 2 diabetes, and NASH. We found that trehalose intake markedly inhibited histopathological features of NASH, particularly hepatic steatosis and liver cell injury, in TSOD mice. Trehalose intake attenuated increase in mesenteric adipose tissue weight, impaired glucose tolerance, and iron deposition in the duodenum, suggesting that trehalose prevents insulin resistance and iron absorption in TSOD mice. These findings indicate that trehalose attenuates the development of NASH associated with type 2 diabetes, and this attenuation may be mediated by prevention of lipid accumulation and iron absorption.
first_indexed 2024-12-17T06:17:49Z
format Article
id doaj.art-bf39ab36d350475eaa17ad1354f8ae58
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-12-17T06:17:49Z
publishDate 2019-05-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-bf39ab36d350475eaa17ad1354f8ae582022-12-21T22:00:28ZengElsevierJournal of Functional Foods1756-46462019-05-0156303311Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouseKazutoshi Murotomi0Shigeyuki Arai1Aki Suyama2Akira Harashima3Yoshihiro Nakajima4Health Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Takamatsu, Kagawa 761-0395, Japan; Corresponding authors.Hayashibara Co., Ltd., Naka-ku, Okayama 702-8006, Japan; Corresponding authors.Hayashibara Co., Ltd., Naka-ku, Okayama 702-8006, JapanHayashibara Co., Ltd., Naka-ku, Okayama 702-8006, JapanHealth Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Takamatsu, Kagawa 761-0395, JapanTrehalose, a non-reducing disaccharide, induces autophagy. Trehalose mitigates insulin resistance and adipocyte hypertrophy in obese mice; however, its effect on the development of nonalcoholic steatohepatitis (NASH) associated with type 2 diabetes remains unknown. In this study, we investigated the effect of trehalose on the development of NASH in the Tsumura Suzuki Obese Diabetes (TSOD) mouse, a metabolic syndrome model characterized by obesity, type 2 diabetes, and NASH. We found that trehalose intake markedly inhibited histopathological features of NASH, particularly hepatic steatosis and liver cell injury, in TSOD mice. Trehalose intake attenuated increase in mesenteric adipose tissue weight, impaired glucose tolerance, and iron deposition in the duodenum, suggesting that trehalose prevents insulin resistance and iron absorption in TSOD mice. These findings indicate that trehalose attenuates the development of NASH associated with type 2 diabetes, and this attenuation may be mediated by prevention of lipid accumulation and iron absorption.http://www.sciencedirect.com/science/article/pii/S1756464619301379TrehaloseNonalcoholic steatohepatitisDiabetesAdiposeIronTSOD mouse
spellingShingle Kazutoshi Murotomi
Shigeyuki Arai
Aki Suyama
Akira Harashima
Yoshihiro Nakajima
Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouse
Journal of Functional Foods
Trehalose
Nonalcoholic steatohepatitis
Diabetes
Adipose
Iron
TSOD mouse
title Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouse
title_full Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouse
title_fullStr Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouse
title_full_unstemmed Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouse
title_short Trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in TSOD mouse
title_sort trehalose attenuates development of nonalcoholic steatohepatitis associated with type 2 diabetes in tsod mouse
topic Trehalose
Nonalcoholic steatohepatitis
Diabetes
Adipose
Iron
TSOD mouse
url http://www.sciencedirect.com/science/article/pii/S1756464619301379
work_keys_str_mv AT kazutoshimurotomi trehaloseattenuatesdevelopmentofnonalcoholicsteatohepatitisassociatedwithtype2diabetesintsodmouse
AT shigeyukiarai trehaloseattenuatesdevelopmentofnonalcoholicsteatohepatitisassociatedwithtype2diabetesintsodmouse
AT akisuyama trehaloseattenuatesdevelopmentofnonalcoholicsteatohepatitisassociatedwithtype2diabetesintsodmouse
AT akiraharashima trehaloseattenuatesdevelopmentofnonalcoholicsteatohepatitisassociatedwithtype2diabetesintsodmouse
AT yoshihironakajima trehaloseattenuatesdevelopmentofnonalcoholicsteatohepatitisassociatedwithtype2diabetesintsodmouse